ML24128A218

Shine Technologies, LLC, Annual Financial Report - Affidavit of Jeff Bartelme

ML24128A218
Person / Time
Site:	SHINE Medical Technologies
Issue date:	05/07/2024
From:	Bartelme J SHINE Technologies
To:	Office of Nuclear Reactor Regulation
Shared Package
ML24128A215	List: ML24128A216 ML24128A218
References
2024-SMT-0025
Download: ML24128A218 (1)

Text

ENCLOSURE 2

SHINE TECHNOLOGIES, LLC

SHINE TECHNOLOGIES, LLC SUBMITTAL OF ANNUAL FINANCIAL REPORT

AFFIDAVIT OF JEFF BARTELME

2 pages follow AFFIDAVIT OF JEFF BARTELME

STATE OF WISCONSIN )

)ss.

COUNTY OF ROCK )

I, Jeff Bartelme, Senior Director of Licensing and Regulatory Affairs of SHINE Technologies, LLC (SHINE), do hereby affirm and state:

1. I am authorized to execute this affidavit on behalf of SHINE. I am authorized to review information submitted to or discussed with the Nuclear Regulatory Commission (NRC) and apply for the withholding of information from public disclosure. The purpose of this affidavit is to provide the information required by 10 CFR 2.390(b) in support of SHINEs request for proprietary treatment of certain confidential commercial and financial information submitted in the annual financial report by letter 2024-SMT-0025 with enclosures. SHINE requests that the confidential information contained in Enclosure 1 be withheld from public disclosure in its entirety.

2. I have knowledge of the criteria used by SHINE in designating information as sensitive, proprietary, or confidential.

3. Pursuant to the provisions of paragraph (a)(4) of 10 CFR 2.390, the following is furnished for consideration by the NRC in determining whether the information sought to be withheld from public disclosure should be withheld.

a. The information sought to be withheld from public disclosure contained in Enclosure 1 of 2024-SMT-0025 is owned by SHINE, its affiliates, or third parties to whom SHINE has an obligation to maintain its confidentiality. This information is and has been held in confidence by SHINE.

b. The information sought to be protected in Enclosure 1 is not available to the public to the best of my knowledge and belief.

c. The information contained in Enclosure 1 is of the type that is customarily held in confidence by SHINE, and there is a rational basis for doing so. The information that SHINE is requesting to be withheld from public disclosure includes trade secret, commercial financial information, commercial information, or information that is subject to export controls. SHINE limits access to these elements to those with a need to know, and subject to maintaining confidentiality.

1


     

  



G Public disclosure of the information in Enclosure 1 would create substantial 

harm to SHINE because it would reveal valuable business information 

regarding SHINE's competitive expectations, assumptions, processes, and 

current position. Its use by a competitor could substantially improve their 

competitive position in the design, manufacture, shipment, installation, 

assurance of quality, or licensing of a similar product.

H The information contained in Enclosure 1 of 2024-SMT-0025 is transmitted to 

the NRC in confidence and under the provisions of 10 CFR 2.390; it is to be 

received in confidence by the NRC. The information is properly marked.

I declare under the penalty of perjury that the foregoing is true and correct.

Executed on May 7, 2024.

Jeff Bartelme Senior Director of Licensing and Regulatory Affairs SHINE Technologies, LLC

2